-
effectivehealthcare.ahrq.gov/products/ptsd-pharm-non-pharm-treatment/protocol
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
May 01, 2019 - fertility, age at
menopause, quality of life)
Adverse Effects-Child
• Short-term (congenital
anomalies, death … Low (1 study
with potential
risk of bias)
Neonatal Death 1 RCT96 (1000) No difference: no significant … difference in neonatal death
rates between oral agents and
acupuncture strategies. … difference
congenital abnormalities with fresh
versus frozen embryo transfer
Low (1 study)
Neonatal Death
-
effectivehealthcare.ahrq.gov/products/diabetes-update-2015/research-protocol
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023863-cartmell-final-report-2018.pdf
January 01, 2018 - have had a heart
attack, stopping smoking can decrease the risk of subsequent heart attacks, sudden cardiac … death, and
total mortality by 50% (16).
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
December 31, 2013 - 1 year
Composite
outcome of
hospitalizati
on for acute
myocardial
infarction or
stroke, or
death
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
June 12, 2012 - General One specific CEUS stress echo study concluded that there was no
short-term or long-term risk of death … patients
worldwide, carefully documented, have
received echo contrast without evidence of
increased death … patients world-
wide, carefully documented, have received echo contrast without
evidence of increased death … Clinical outcomes (e.g., death, myocardial infarction, unstable
angina, hospitalization, revascularization
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
January 01, 2014 - completed phase
three trials55 showed that
fidaxomicin reduced persistent
diarrhea, recurrence or death … The authors found
were no differences in the incidence of death or serious
adverse events between the … days
-Vancomycin 125
mg four times daily
for 10 days
Persistent diarrhea, recurrence
of CDI, or death … Compared with vancomycin,
fidaxomicin reduced persistent
diarrhea, CDI recurrence, and
death by 40%
-
hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2010-2014.jsp
January 01, 2014 - We retained discharges that resulted in an in-hospital death because these were possible readmission … Discharges that resulted in an in-hospital death were included because these were possible readmission … Discharge may be to the same or a different hospital (HOSP_NRD) and may result in a death. … (0) admission on Monday-Friday, (1) admission on Saturday-Sunday
DIED
Indicates in-hospital death
-
hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2013.pdf
January 01, 2013 - We retained
discharges that resulted in an in-hospital death because these were possible readmission … Discharges that resulted in an in-hospital death were included because these were
possible readmission … Discharge may be to the same or a different hospital (HOSP_NRD) and may result in a
death. … : (0) admission on
Monday–Friday, (1) admission on Saturday–
Sunday
DIED
Indicates in-hospital death
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - prosthetic joint infections, and the need for reoperation,
which may all lead to major morbidities, death … Two studies described
them as treatment-related events that lead to death, are
life-threatening, require … PE makes difficult
a definitive answer to whether thromboprophylaxis
is effective to reduce PE or death … all
VTE outcomes, it is not possible to assess whether total
DVT is an appropriate proxy for PE, death
-
effectivehealthcare.ahrq.gov/sites/default/files/thromboembolism-update-executive-170622.pdf
June 01, 2017 - prosthetic joint infections, and the need for reoperation,
which may all lead to major morbidities, death … Two studies described
them as treatment-related events that lead to death, are
life-threatening, require … PE makes difficult
a definitive answer to whether thromboprophylaxis
is effective to reduce PE or death … all
VTE outcomes, it is not possible to assess whether total
DVT is an appropriate proxy for PE, death
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs023960-rudin-final-report-2018.pdf
January 01, 2018 - Using mHealth and Patient-Reported Outcomes to Deliver Evidence-Based Asthma Care - Final Report
Using mHealth and Patient-Reported Outcomes to Deliver Evidence-Based Asthma Care
Final Report
Principal Investigator and Team Members: Robert S. Rudin, PI; Maria O. Edelen, Co-I; David W.
Bates, Co…
-
psnet.ahrq.gov/web-mm/updates-management-high-risk-pulmonary-embolism
December 02, 2020 - Updates in the Management of High-Risk Pulmonary Embolism
Citation Text:
Kabrhel C, Aaronson E. Updates in the Management of High-Risk Pulmonary Embolism. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Quality, US Department of Health and Human Services. 2019.
Copy Citation
Forma…
-
psnet.ahrq.gov/node/72589/psn-pdf
December 23, 2020 - Delayed Breast Cancer Diagnosis: A False Sense of
Security.
December 23, 2020
Weingart SN, James TA, Schiff G. Delayed Breast Cancer Diagnosis: A False Sense of Security. PSNet
[internet]. 2020.
https://psnet.ahrq.gov/web-mm/delayed-breast-cancer-diagnosis-false-sense-security
The Case
A 60-year-old woman was se…
-
psnet.ahrq.gov/web-mm/steroids-and-safety-preventing-medication-adverse-events-during-transitions-care
September 09, 2013 - SPOTLIGHT CASE
Steroids and Safety: Preventing Medication Adverse Events During Transitions of Care
Citation Text:
Lucier DJ, Greenwald JL. Steroids and Safety: Preventing Medication Adverse Events During Transitions of Care. PSNet [internet]. Rockville (MD): Agency for Healthcare Research and Qu…
-
psnet.ahrq.gov/node/865413/psn-pdf
March 27, 2024 - In Conversation with...Barbara Pelletreau and John Riggi
about Cybersecurity
March 27, 2024
Pelletreau B, Riggi J. In Conversation with..Barbara Pelletreau and John Riggi about Cybersecurity. PSNet
[internet]. 2024.
https://psnet.ahrq.gov/perspective/conversation-withbarbara-pelletreau-and-john-riggi-about-cyberse…
-
psnet.ahrq.gov/node/33833/psn-pdf
May 01, 2017 - In Conversation With… David Juurlink, MD, PhD
May 1, 2017
In Conversation With… David Juurlink, MD, PhD. PSNet [internet]. 2017.
https://psnet.ahrq.gov/perspective/conversation-david-juurlink-md-phd
Editor's note: Dr. Juurlink is professor of medicine, pediatrics, and health policy at the University of
Toronto, w…
-
psnet.ahrq.gov/node/49721/psn-pdf
December 01, 2014 - Ebola: Are We Ready?
December 1, 2014
Barsuk JH, Barnard C. Ebola: Are We Ready? PSNet [internet]. 2014.
https://psnet.ahrq.gov/web-mm/ebola-are-we-ready
The Case
A 28-year-old man, well-appearing but pale, walked into the emergency department (ED) on a Wednesday
afternoon at 3 PM complaining of nausea, vomiting,…
-
psnet.ahrq.gov/sites/default/files/2023-06/hurried_huddle_0.pdf
January 01, 2023 - Microsoft PowerPoint - Spotlight Case_Anesthesia Error During Cesarean_06.22.2023 - Final.pptx
Spotlight
Hurried Team Huddle and Poor Communication: Unsafe
Practice During Anesthesia for Emergency Cesarean
Delivery
Source and Credits
• This presentation is based on the June 2023 AHRQ WebM&M
Spotlight Case
o See…
-
www.ahrq.gov/hai/cusp/clabsi-final-companion/clabsicompapc.html
January 01, 2013 - Eliminating CLABSI, A National Patient Safety Imperative: Final Report Companion Guide
Appendix C. Article Exclusion List with Reason for Exclusion
Previous Page Next Page
Table of Contents
Eliminating CLABSI, A National Patient Safety Imperative: Final Report Companion Guide
Preface
Methods
P…